disease 5,291 words KG: ent-dise-06dd4f81
Contents

Alzheimer's Disease

Disease Info
Amyloid-beta plaquesExtracellular deposits of Aβ peptides (Aβ40, Aβ42)
Neurofibrillary tanglesIntracellular tau protein aggregates (paired helical filaments)
Neuronal lossProgressive death of synapses and neurons, particularly in hippocampus and cortex
Neuroinflammationchronic activation of microglia and astrocytes; the NF-κB Signaling pathway regulates this response
Synaptic dysfunctionEarly loss of synaptic markers and function
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (190)

Mitochondrial Calcium Buffering Enhancement via MCU Modulati
Score: 0.65
APOE-Mediated Synaptic Lipid Raft Stabilization
Score: 0.65
Glial Glycocalyx Remodeling Therapy
Score: 0.65
DNMT1-Targeting Antisense Oligonucleotide Reset
Score: 0.65
HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.65
Mitochondrial SPM Synthesis Platform Engineering
Score: 0.65
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
Score: 0.65
Synthetic Biology Rewiring via Orthogonal Receptors
Score: 0.65
Glycine-Rich Domain Competitive Inhibition
Score: 0.64
Transglutaminase-2 Cross-Linking Inhibition Strategy
Score: 0.64
FOXO3-Longevity Pathway Epigenetic Reprogramming
Score: 0.63
Programmable Neuronal Circuit Repair via Epigenetic CRISPR
Score: 0.63
Multi-Modal CRISPR Platform for Simultaneous Editing and Mon
Score: 0.63
Quantum Coherence Disruption in Cellular Communication
Score: 0.63
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.62
Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics
Score: 0.62
Serine/Arginine-Rich Protein Kinase Modulation
Score: 0.62
TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.62
Cholesterol-CRISPR Convergence Therapy for Neurodegeneration
Score: 0.62
Pharmacological Enhancement of APOE4 Glycosylation
Score: 0.62
← Prevpg 7/10Next →

Related Analyses (30)

SEA-AD Single-Cell Analysis: Cell-Type Vulnerability in Alzh
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived

Related Experiments (30)

CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.51
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.45
Lifestyle Intervention Mechanisms in Alzheimer's Disease
validation · proposed · Score: 0.40

See Also (15)

ASL Perfusion Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
Digital Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
Dried Blood Spot Biomarker Test for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
DTI Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
EEG Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.